Literature DB >> 9455648

Brush cytology in the diagnosis of neoplasia in Barrett's esophagus.

R H Hardwick1, R J Morgan, B F Warren, M Lott, D Alderson.   

Abstract

Esophageal cytology may improve sensitivity for the detection of malignancy but can be difficult to interpret in the presence of inflammation. To assess the value of cytology in assessing patients with Barrett's esophagus a retrospective review was performed. One hundred and sixty two patients (87 esophageal/gastroesophageal junction adenocarcinoma, 65 non-dysplastic Barrett's esophagus and 10 dysplastic Barrett's esophagus) had biopsies and brushings taken for histological and cytological assessment. Eighty two of 92 patients with carcinoma or high-grade dysplasia had true positive malignant cytology. Seven of 65 patients with non-dysplastic but inflamed Barrett's esophagus had false positive malignant cytology. One of these patients had an esophagectomy on the basis of cytology but no tumor was found in the resection specimen. This translates into an 89% sensitivity and specificity of cytology for the detection of esophageal columnar neoplasia. Cytology from Barrett's esophagus can be misleading in the presence of severe inflammation. Cells from a benign Barrett's ulcer may appear frankly malignant when examined in isolation. Esophagectomy should not be performed on the basis of cytological evidence alone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9455648     DOI: 10.1093/dote/10.4.233

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  5 in total

1.  Automated cytological detection of Barrett's neoplasia with infrared spectroscopy.

Authors:  Oliver Old; Gavin Lloyd; Martin Isabelle; L Max Almond; Catherine Kendall; Karol Baxter; Neil Shepherd; Angela Shore; Nick Stone; Hugh Barr
Journal:  J Gastroenterol       Date:  2017-05-13       Impact factor: 7.527

2.  Usefulness of endoscopic brushing and magnified endoscopy with narrow band imaging (ME-NBI) to detect intestinal phenotype in columnar-lined esophagus.

Authors:  Takahisa Murao; Akiko Shiotani; Yoshiyuki Yamanaka; Yoshiki Kimura; Hideaki Tsutsui; Hiroshi Matsumoto; Tomoari Kamada; Noriaki Manabe; Jiro Hata; Ken Haruma
Journal:  J Gastroenterol       Date:  2012-05-11       Impact factor: 7.527

Review 3.  Screening for Barrett's Esophagus.

Authors:  Massimiliano di Pietro; Daniel Chan; Rebecca C Fitzgerald; Kenneth K Wang
Journal:  Gastroenterology       Date:  2015-02-17       Impact factor: 22.682

4.  Validation of the use of a fluorescent PARP1 inhibitor for the detection of oral, oropharyngeal and oesophageal epithelial cancers.

Authors:  Susanne Kossatz; Giacomo Pirovano; Paula Demétrio De Souza França; Arianna L Strome; Sumsum P Sunny; Daniella Karassawa Zanoni; Audrey Mauguen; Brandon Carney; Christian Brand; Veer Shah; Ravindra D Ramanajinappa; Naveen Hedne; Praveen Birur; Smita Sihag; Ronald A Ghossein; Mithat Gönen; Marshall Strome; Amritha Suresh; Daniela Molena; Ian Ganly; Moni A Kuriakose; Snehal G Patel; Thomas Reiner
Journal:  Nat Biomed Eng       Date:  2020-03-12       Impact factor: 25.671

Review 5.  Relationship between the expression of hTERT and EYA4 mRNA in peripheral blood mononuclear cells with the progressive stages of carcinogenesis of the esophagus.

Authors:  Hao Li; Tao Yu Diao; Zhi Ying Zhou; Fang Yan Yang; Qing Ma; Qing Hui Li
Journal:  J Exp Clin Cancer Res       Date:  2009-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.